Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
2526
DELISTED
LHC Group LLC
LHCG
| $1.25M | ﹤0.01% |
9,069
-13,600
| -60% | -$1.69M |
|
2527
Hennessy Advisors
HNNA
$77.7M
| $1.25M | ﹤0.01% |
123,725
+14,201
| +13% | +$158K |
|
|
PACD
2528
DELISTED
Pacific Drilling S.A. Common Shares
PACD
| $1.24M | ﹤0.01% |
304,900
+49,200
| +19% | +$154K |
|
2529
Hallador Energy
HNRG
$670M
| $1.24M | ﹤0.01% |
416,058
-72,400
| -15% | -$222K |
|
|
SUP
2530
DELISTED
Superior Industries International
SUP
| $1.24M | ﹤0.01% |
+334,959
| New | +$1.02M |
|
2531
Movado Group
MOV
$849M
| $1.23M | ﹤0.01% |
56,536
-226,300
| -80% | -$5.29M |
|
2532
BGSF Inc
BGSF
$59.5M
| $1.23M | ﹤0.01% |
56,000
+18,300
| +49% | +$373K |
|
2533
Unity Bancorp
UNTY
$591M
| $1.23M | ﹤0.01% |
54,301
+10,401
| +24% | +$230K |
|
2534
iShares Russell 3000 ETF
IWV
$19.6B
| $1.23M | ﹤0.01% |
+6,500
| New | +$1.17M |
|
2535
Broadwind
BWEN
$93.6M
| $1.22M | ﹤0.01% |
737,200
| – | – |
|
|
GDP
2536
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $1.22M | ﹤0.01% |
121,900
+500
| +0.4% | +$4.86K |
|
|
EMMS
2537
DELISTED
Emmis Communications Corp
EMMS
| $1.22M | ﹤0.01% |
323,221
+24,536
| +8% | +$105K |
|
2538
Babcock & Wilcox
BW
$1.39B
| $1.22M | ﹤0.01% |
333,950
+68,770
| +26% | +$269K |
|
2539
Beasley Broadcasting Group
BBGI
$37.8M
| $1.21M | ﹤0.01% |
19,596
+2,686
| +16% | +$158K |
|
|
SHLO
2540
DELISTED
Shiloh Industries Inc
SHLO
| $1.21M | ﹤0.01% |
339,811
+48,300
| +17% | +$186K |
|
2541
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
| $1.21M | ﹤0.01% |
+104,000
| New | +$1.15M |
|
|
INFI
2542
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.21M | ﹤0.01% |
1,258,313
+137,373
| +12% | +$151K |
|
2543
Heritage Financial
HFWA
$1.22B
| $1.2M | ﹤0.01% |
42,499
-26,090
| -38% | -$720K |
|
2544
Qfin Holdings
QFIN
$1.69B
| $1.2M | ﹤0.01% |
+122,700
| New | +$1.11M |
|
|
ICBK
2545
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $1.2M | ﹤0.01% |
46,671
-3,442
| -7% | -$79.8K |
|
2546
NI Holdings
NODK
$310M
| $1.2M | ﹤0.01% |
69,501
-5,100
| -7% | -$87.4K |
|
|
ELGX
2547
DELISTED
Endologix Inc
ELGX
| $1.19M | ﹤0.01% |
755,668
+44,400
| +6% | +$124K |
|
2548
KraneShares CSI China Internet ETF
KWEB
$5.64B
| $1.19M | ﹤0.01% |
+24,500
| New | +$1.12M |
|
|
CMLS
2549
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $1.19M | ﹤0.01% |
67,804
+54,016
| +392% | +$827K |
|
|
AKCA
2550
DELISTED
Akcea Therapeutics Inc
AKCA
| $1.19M | ﹤0.01% |
+70,200
| New | +$1.31M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.